Risankizumab Safe in Older Crohn’s Disease Patients
In a post-hoc analysis of the ADVANCE and MOTIVATE phase III induction studies, along with…
Browsing Tag
Crohns
Reaction to FDA’s Approval of Upadacitinib for Crohn’s Disease
The FDA recently approved upadacitinib (Rinvoq) for treating Crohn's disease, the first Janus…
New Model Aims to Study Intestinal Fibrosis in Crohn’s Disease
Intestinal fibrosis is a serious complication of Crohn's disease (CD) without any approved…
A Close Look at the Data Backing Upadacitinib’s Approval in Crohn’s
The selective Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) improved…
At-Home Device Can Predict Crohn’s Disease Flares
A new at-home monitoring device developed at Massachusetts Institute of Technology (MIT)…
Celularity Announces Phase 1 Data Showing That MLASC Therapy in Patients With Crohn’s…
<!-- Name:DistributionId Value:8843168 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
First JAK Inhibitor Approved for Crohn’s Disease
The FDA approved upadacitinib (Rinvoq) for treating Crohn's disease,…
‘Creeping’ Closer to Understanding Crohn’s Disease
Investigators at the Cleveland Clinic are exploring the possibility that blocking "creeping…
Win for Vedolizumab in Recurrent Crohn’s Disease
CHICAGO -- Patients receiving vedolizumab (Entyvio) after undergoing bowel resection for advanced Crohn's disease in a…
DelveInsight Highlights Major Advances, Transformative Therapies, and 80+ Leading…
<!-- Name:DistributionId Value:8809012 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…